nodes	percent_of_prediction	percent_of_DWPC	metapath
Modafinil—CYP3A5—Gefitinib—lung cancer	0.0458	0.0715	CbGbCtD
Modafinil—CYP3A5—Teniposide—lung cancer	0.0444	0.0693	CbGbCtD
Modafinil—CYP2C19—Gefitinib—lung cancer	0.037	0.0576	CbGbCtD
Modafinil—CYP2C19—Teniposide—lung cancer	0.0358	0.0559	CbGbCtD
Modafinil—CYP2B6—Irinotecan—lung cancer	0.0311	0.0484	CbGbCtD
Modafinil—CYP2C9—Gefitinib—lung cancer	0.0307	0.0479	CbGbCtD
Modafinil—CYP2C9—Teniposide—lung cancer	0.0298	0.0465	CbGbCtD
Modafinil—CYP3A5—Crizotinib—lung cancer	0.0281	0.0438	CbGbCtD
Modafinil—CYP3A5—Erlotinib—lung cancer	0.0271	0.0423	CbGbCtD
Modafinil—CYP2B6—Cisplatin—lung cancer	0.0253	0.0395	CbGbCtD
Modafinil—CYP3A5—Paclitaxel—lung cancer	0.0248	0.0387	CbGbCtD
Modafinil—CYP3A5—Irinotecan—lung cancer	0.0245	0.0382	CbGbCtD
Modafinil—CYP1A2—Erlotinib—lung cancer	0.0202	0.0314	CbGbCtD
Modafinil—CYP3A5—Etoposide—lung cancer	0.0196	0.0306	CbGbCtD
Modafinil—CYP3A4—Topotecan—lung cancer	0.0195	0.0305	CbGbCtD
Modafinil—CYP3A5—Docetaxel—lung cancer	0.0179	0.028	CbGbCtD
Modafinil—CYP3A4—Gefitinib—lung cancer	0.0179	0.0279	CbGbCtD
Modafinil—CYP3A4—Teniposide—lung cancer	0.0173	0.027	CbGbCtD
Modafinil—CYP2B6—Doxorubicin—lung cancer	0.017	0.0265	CbGbCtD
Modafinil—CYP2C9—Paclitaxel—lung cancer	0.0166	0.0259	CbGbCtD
Modafinil—CYP1A2—Etoposide—lung cancer	0.0146	0.0227	CbGbCtD
Modafinil—CYP3A4—Vinorelbine—lung cancer	0.0138	0.0215	CbGbCtD
Modafinil—CYP2C9—Cisplatin—lung cancer	0.0134	0.0209	CbGbCtD
Modafinil—CYP3A4—Crizotinib—lung cancer	0.011	0.0171	CbGbCtD
Modafinil—CYP3A4—Erlotinib—lung cancer	0.0106	0.0165	CbGbCtD
Modafinil—CYP3A4—Paclitaxel—lung cancer	0.00967	0.0151	CbGbCtD
Modafinil—CYP3A4—Irinotecan—lung cancer	0.00954	0.0149	CbGbCtD
Modafinil—CYP3A4—Vinblastine—lung cancer	0.00848	0.0132	CbGbCtD
Modafinil—CYP3A4—Etoposide—lung cancer	0.00764	0.0119	CbGbCtD
Modafinil—CYP3A4—Docetaxel—lung cancer	0.00699	0.0109	CbGbCtD
Modafinil—CYP3A4—Doxorubicin—lung cancer	0.00521	0.00813	CbGbCtD
Modafinil—Levomethadyl Acetate—CHRNB4—lung cancer	0.000983	0.19	CrCbGaD
Modafinil—Levomethadyl Acetate—CHRNA3—lung cancer	0.000681	0.132	CrCbGaD
Modafinil—Ketoprofen—CXCL8—lung cancer	0.000356	0.0688	CrCbGaD
Modafinil—Bifonazole—CYP2E1—lung cancer	0.000272	0.0526	CrCbGaD
Modafinil—Nepafenac—PTGS2—lung cancer	0.000256	0.0495	CrCbGaD
Modafinil—Cinnarizine—CYP2A6—lung cancer	0.000243	0.0471	CrCbGaD
Modafinil—Warfarin—CYP1A1—lung cancer	0.000215	0.0416	CrCbGaD
Modafinil—Oxaprozin—PTGS2—lung cancer	0.000213	0.0411	CrCbGaD
Modafinil—Fosphenytoin—ALB—lung cancer	0.000197	0.0381	CrCbGaD
Modafinil—Fenoprofen—PTGS2—lung cancer	0.000176	0.034	CrCbGaD
Modafinil—Cinnarizine—CYP1A1—lung cancer	0.00017	0.033	CrCbGaD
Modafinil—Fenoprofen—ALB—lung cancer	0.000157	0.0303	CrCbGaD
Modafinil—Phenylbutazone—PTGS2—lung cancer	0.000141	0.0272	CrCbGaD
Modafinil—Phenprocoumon—ALB—lung cancer	0.000135	0.0261	CrCbGaD
Modafinil—Oxcarbazepine—ALB—lung cancer	0.000131	0.0254	CrCbGaD
Modafinil—Warfarin—ALB—lung cancer	0.00012	0.0232	CrCbGaD
Modafinil—Orphenadrine—CYP2E1—lung cancer	0.000117	0.0227	CrCbGaD
Modafinil—Asthenia—Irinotecan—lung cancer	0.000111	0.000462	CcSEcCtD
Modafinil—Fatigue—Etoposide—lung cancer	0.000111	0.000462	CcSEcCtD
Modafinil—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000111	0.000461	CcSEcCtD
Modafinil—Constipation—Etoposide—lung cancer	0.00011	0.000458	CcSEcCtD
Modafinil—Pain—Etoposide—lung cancer	0.00011	0.000458	CcSEcCtD
Modafinil—Decreased appetite—Paclitaxel—lung cancer	0.000109	0.000457	CcSEcCtD
Modafinil—Dry mouth—Docetaxel—lung cancer	0.000109	0.000454	CcSEcCtD
Modafinil—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000109	0.000454	CcSEcCtD
Modafinil—Fatigue—Paclitaxel—lung cancer	0.000109	0.000453	CcSEcCtD
Modafinil—Pollakiuria—Doxorubicin—lung cancer	0.000108	0.000452	CcSEcCtD
Modafinil—Asthenia—Gemcitabine—lung cancer	0.000108	0.00045	CcSEcCtD
Modafinil—Constipation—Paclitaxel—lung cancer	0.000108	0.000449	CcSEcCtD
Modafinil—Pain—Paclitaxel—lung cancer	0.000108	0.000449	CcSEcCtD
Modafinil—Confusional state—Docetaxel—lung cancer	0.000108	0.000449	CcSEcCtD
Modafinil—Pharyngitis—Methotrexate—lung cancer	0.000107	0.000448	CcSEcCtD
Modafinil—Urinary tract disorder—Methotrexate—lung cancer	0.000107	0.000446	CcSEcCtD
Modafinil—Photosensitivity reaction—Doxorubicin—lung cancer	0.000107	0.000446	CcSEcCtD
Modafinil—Anaphylactic shock—Docetaxel—lung cancer	0.000107	0.000445	CcSEcCtD
Modafinil—Oedema—Docetaxel—lung cancer	0.000107	0.000445	CcSEcCtD
Modafinil—Weight increased—Doxorubicin—lung cancer	0.000107	0.000445	CcSEcCtD
Modafinil—Pruritus—Gemcitabine—lung cancer	0.000106	0.000444	CcSEcCtD
Modafinil—Urethral disorder—Methotrexate—lung cancer	0.000106	0.000443	CcSEcCtD
Modafinil—Infection—Docetaxel—lung cancer	0.000106	0.000442	CcSEcCtD
Modafinil—Weight decreased—Doxorubicin—lung cancer	0.000106	0.000442	CcSEcCtD
Modafinil—Feeling abnormal—Etoposide—lung cancer	0.000106	0.000442	CcSEcCtD
Modafinil—Hyperglycaemia—Doxorubicin—lung cancer	0.000106	0.000441	CcSEcCtD
Modafinil—Diarrhoea—Irinotecan—lung cancer	0.000106	0.000441	CcSEcCtD
Modafinil—Pneumonia—Doxorubicin—lung cancer	0.000105	0.000438	CcSEcCtD
Modafinil—Gastrointestinal pain—Etoposide—lung cancer	0.000105	0.000438	CcSEcCtD
Modafinil—Shock—Docetaxel—lung cancer	0.000105	0.000438	CcSEcCtD
Modafinil—Nervous system disorder—Docetaxel—lung cancer	0.000105	0.000437	CcSEcCtD
Modafinil—Drowsiness—Doxorubicin—lung cancer	0.000104	0.000436	CcSEcCtD
Modafinil—Visual impairment—Methotrexate—lung cancer	0.000104	0.000435	CcSEcCtD
Modafinil—Tachycardia—Docetaxel—lung cancer	0.000104	0.000435	CcSEcCtD
Modafinil—Feeling abnormal—Paclitaxel—lung cancer	0.000104	0.000433	CcSEcCtD
Modafinil—Ketoprofen—PTGS2—lung cancer	0.000104	0.0201	CrCbGaD
Modafinil—Skin disorder—Docetaxel—lung cancer	0.000104	0.000433	CcSEcCtD
Modafinil—Stevens-Johnson syndrome—Doxorubicin—lung cancer	0.000104	0.000432	CcSEcCtD
Modafinil—Hypersensitivity—Cisplatin—lung cancer	0.000103	0.000431	CcSEcCtD
Modafinil—Gastrointestinal pain—Paclitaxel—lung cancer	0.000103	0.00043	CcSEcCtD
Modafinil—Diarrhoea—Gemcitabine—lung cancer	0.000103	0.000429	CcSEcCtD
Modafinil—Erythema multiforme—Methotrexate—lung cancer	0.000102	0.000427	CcSEcCtD
Modafinil—Dizziness—Irinotecan—lung cancer	0.000102	0.000426	CcSEcCtD
Modafinil—Urticaria—Etoposide—lung cancer	0.000102	0.000426	CcSEcCtD
Modafinil—Stomatitis—Doxorubicin—lung cancer	0.000102	0.000425	CcSEcCtD
Modafinil—Anorexia—Docetaxel—lung cancer	0.000102	0.000425	CcSEcCtD
Modafinil—Abdominal pain—Etoposide—lung cancer	0.000102	0.000424	CcSEcCtD
Modafinil—Body temperature increased—Etoposide—lung cancer	0.000102	0.000424	CcSEcCtD
Modafinil—Conjunctivitis—Doxorubicin—lung cancer	0.000102	0.000424	CcSEcCtD
Modafinil—Urinary tract infection—Doxorubicin—lung cancer	0.000102	0.000424	CcSEcCtD
Modafinil—Asthenia—Cisplatin—lung cancer	0.000101	0.00042	CcSEcCtD
Modafinil—Cardiac disorder—Methotrexate—lung cancer	0.0001	0.000419	CcSEcCtD
Modafinil—Sweating—Doxorubicin—lung cancer	0.0001	0.000418	CcSEcCtD
Modafinil—Urticaria—Paclitaxel—lung cancer	0.0001	0.000417	CcSEcCtD
Modafinil—Hypotension—Docetaxel—lung cancer	9.97e-05	0.000416	CcSEcCtD
Modafinil—Haematuria—Doxorubicin—lung cancer	9.96e-05	0.000416	CcSEcCtD
Modafinil—Abdominal pain—Paclitaxel—lung cancer	9.95e-05	0.000415	CcSEcCtD
Modafinil—Body temperature increased—Paclitaxel—lung cancer	9.95e-05	0.000415	CcSEcCtD
Modafinil—Epistaxis—Doxorubicin—lung cancer	9.85e-05	0.000411	CcSEcCtD
Modafinil—Angiopathy—Methotrexate—lung cancer	9.82e-05	0.00041	CcSEcCtD
Modafinil—Vomiting—Irinotecan—lung cancer	9.82e-05	0.00041	CcSEcCtD
Modafinil—Sinusitis—Doxorubicin—lung cancer	9.8e-05	0.000409	CcSEcCtD
Modafinil—Immune system disorder—Methotrexate—lung cancer	9.78e-05	0.000408	CcSEcCtD
Modafinil—Mediastinal disorder—Methotrexate—lung cancer	9.76e-05	0.000407	CcSEcCtD
Modafinil—Agranulocytosis—Doxorubicin—lung cancer	9.75e-05	0.000407	CcSEcCtD
Modafinil—Rash—Irinotecan—lung cancer	9.74e-05	0.000406	CcSEcCtD
Modafinil—Dermatitis—Irinotecan—lung cancer	9.73e-05	0.000406	CcSEcCtD
Modafinil—Musculoskeletal discomfort—Docetaxel—lung cancer	9.72e-05	0.000406	CcSEcCtD
Modafinil—Chills—Methotrexate—lung cancer	9.72e-05	0.000405	CcSEcCtD
Modafinil—Headache—Irinotecan—lung cancer	9.67e-05	0.000404	CcSEcCtD
Modafinil—Insomnia—Docetaxel—lung cancer	9.65e-05	0.000403	CcSEcCtD
Modafinil—Diarrhoea—Cisplatin—lung cancer	9.59e-05	0.0004	CcSEcCtD
Modafinil—Paraesthesia—Docetaxel—lung cancer	9.58e-05	0.0004	CcSEcCtD
Modafinil—Vomiting—Gemcitabine—lung cancer	9.56e-05	0.000399	CcSEcCtD
Modafinil—Bradycardia—Doxorubicin—lung cancer	9.54e-05	0.000398	CcSEcCtD
Modafinil—Dyspnoea—Docetaxel—lung cancer	9.52e-05	0.000397	CcSEcCtD
Modafinil—Somnolence—Docetaxel—lung cancer	9.49e-05	0.000396	CcSEcCtD
Modafinil—Mental disorder—Methotrexate—lung cancer	9.49e-05	0.000396	CcSEcCtD
Modafinil—Rash—Gemcitabine—lung cancer	9.48e-05	0.000396	CcSEcCtD
Modafinil—Dermatitis—Gemcitabine—lung cancer	9.47e-05	0.000395	CcSEcCtD
Modafinil—Hypersensitivity—Etoposide—lung cancer	9.46e-05	0.000395	CcSEcCtD
Modafinil—Malnutrition—Methotrexate—lung cancer	9.43e-05	0.000393	CcSEcCtD
Modafinil—Headache—Gemcitabine—lung cancer	9.42e-05	0.000393	CcSEcCtD
Modafinil—Rhinitis—Doxorubicin—lung cancer	9.4e-05	0.000392	CcSEcCtD
Modafinil—Dyspepsia—Docetaxel—lung cancer	9.4e-05	0.000392	CcSEcCtD
Modafinil—Pharyngitis—Doxorubicin—lung cancer	9.31e-05	0.000388	CcSEcCtD
Modafinil—Decreased appetite—Docetaxel—lung cancer	9.28e-05	0.000387	CcSEcCtD
Modafinil—Hypersensitivity—Paclitaxel—lung cancer	9.28e-05	0.000387	CcSEcCtD
Modafinil—Urinary tract disorder—Doxorubicin—lung cancer	9.26e-05	0.000386	CcSEcCtD
Modafinil—Ketoprofen—ALB—lung cancer	9.24e-05	0.0179	CrCbGaD
Modafinil—Oedema peripheral—Doxorubicin—lung cancer	9.24e-05	0.000385	CcSEcCtD
Modafinil—Dysgeusia—Methotrexate—lung cancer	9.23e-05	0.000385	CcSEcCtD
Modafinil—Gastrointestinal disorder—Docetaxel—lung cancer	9.21e-05	0.000385	CcSEcCtD
Modafinil—Asthenia—Etoposide—lung cancer	9.21e-05	0.000385	CcSEcCtD
Modafinil—Connective tissue disorder—Doxorubicin—lung cancer	9.21e-05	0.000384	CcSEcCtD
Modafinil—Fatigue—Docetaxel—lung cancer	9.2e-05	0.000384	CcSEcCtD
Modafinil—Urethral disorder—Doxorubicin—lung cancer	9.19e-05	0.000384	CcSEcCtD
Modafinil—Nausea—Irinotecan—lung cancer	9.17e-05	0.000383	CcSEcCtD
Modafinil—Fentanyl—ABCB1—lung cancer	9.16e-05	0.0177	CrCbGaD
Modafinil—Pain—Docetaxel—lung cancer	9.13e-05	0.000381	CcSEcCtD
Modafinil—Constipation—Docetaxel—lung cancer	9.13e-05	0.000381	CcSEcCtD
Modafinil—Back pain—Methotrexate—lung cancer	9.12e-05	0.00038	CcSEcCtD
Modafinil—Pruritus—Etoposide—lung cancer	9.09e-05	0.000379	CcSEcCtD
Modafinil—Visual impairment—Doxorubicin—lung cancer	9.04e-05	0.000377	CcSEcCtD
Modafinil—Asthenia—Paclitaxel—lung cancer	9.03e-05	0.000377	CcSEcCtD
Modafinil—Nausea—Gemcitabine—lung cancer	8.93e-05	0.000373	CcSEcCtD
Modafinil—Vomiting—Cisplatin—lung cancer	8.91e-05	0.000372	CcSEcCtD
Modafinil—Pruritus—Paclitaxel—lung cancer	8.91e-05	0.000372	CcSEcCtD
Modafinil—Erythema multiforme—Doxorubicin—lung cancer	8.86e-05	0.00037	CcSEcCtD
Modafinil—Rash—Cisplatin—lung cancer	8.84e-05	0.000369	CcSEcCtD
Modafinil—Dermatitis—Cisplatin—lung cancer	8.83e-05	0.000369	CcSEcCtD
Modafinil—Feeling abnormal—Docetaxel—lung cancer	8.8e-05	0.000367	CcSEcCtD
Modafinil—Diarrhoea—Etoposide—lung cancer	8.79e-05	0.000367	CcSEcCtD
Modafinil—Ill-defined disorder—Methotrexate—lung cancer	8.75e-05	0.000365	CcSEcCtD
Modafinil—Gastrointestinal pain—Docetaxel—lung cancer	8.73e-05	0.000364	CcSEcCtD
Modafinil—Anaemia—Methotrexate—lung cancer	8.71e-05	0.000364	CcSEcCtD
Modafinil—Cardiac disorder—Doxorubicin—lung cancer	8.7e-05	0.000363	CcSEcCtD
Modafinil—Phenytoin—ALB—lung cancer	8.7e-05	0.0168	CrCbGaD
Modafinil—Diarrhoea—Paclitaxel—lung cancer	8.62e-05	0.00036	CcSEcCtD
Modafinil—Carbamazepine—ABCB1—lung cancer	8.54e-05	0.0165	CrCbGaD
Modafinil—Angiopathy—Doxorubicin—lung cancer	8.51e-05	0.000355	CcSEcCtD
Modafinil—Malaise—Methotrexate—lung cancer	8.5e-05	0.000355	CcSEcCtD
Modafinil—Dizziness—Etoposide—lung cancer	8.49e-05	0.000354	CcSEcCtD
Modafinil—Immune system disorder—Doxorubicin—lung cancer	8.47e-05	0.000353	CcSEcCtD
Modafinil—Vertigo—Methotrexate—lung cancer	8.47e-05	0.000353	CcSEcCtD
Modafinil—Mediastinal disorder—Doxorubicin—lung cancer	8.45e-05	0.000353	CcSEcCtD
Modafinil—Body temperature increased—Docetaxel—lung cancer	8.44e-05	0.000352	CcSEcCtD
Modafinil—Abdominal pain—Docetaxel—lung cancer	8.44e-05	0.000352	CcSEcCtD
Modafinil—Chills—Doxorubicin—lung cancer	8.41e-05	0.000351	CcSEcCtD
Modafinil—Arrhythmia—Doxorubicin—lung cancer	8.38e-05	0.00035	CcSEcCtD
Modafinil—Dizziness—Paclitaxel—lung cancer	8.33e-05	0.000347	CcSEcCtD
Modafinil—Nausea—Cisplatin—lung cancer	8.33e-05	0.000347	CcSEcCtD
Modafinil—Phenytoin—ABCB1—lung cancer	8.3e-05	0.0161	CrCbGaD
Modafinil—Cough—Methotrexate—lung cancer	8.23e-05	0.000343	CcSEcCtD
Modafinil—Mental disorder—Doxorubicin—lung cancer	8.21e-05	0.000343	CcSEcCtD
Modafinil—Convulsion—Methotrexate—lung cancer	8.17e-05	0.000341	CcSEcCtD
Modafinil—Vomiting—Etoposide—lung cancer	8.17e-05	0.000341	CcSEcCtD
Modafinil—Malnutrition—Doxorubicin—lung cancer	8.16e-05	0.000341	CcSEcCtD
Modafinil—Rash—Etoposide—lung cancer	8.1e-05	0.000338	CcSEcCtD
Modafinil—Dermatitis—Etoposide—lung cancer	8.09e-05	0.000338	CcSEcCtD
Modafinil—Headache—Etoposide—lung cancer	8.05e-05	0.000336	CcSEcCtD
Modafinil—Flatulence—Doxorubicin—lung cancer	8.04e-05	0.000336	CcSEcCtD
Modafinil—Arthralgia—Methotrexate—lung cancer	8.02e-05	0.000335	CcSEcCtD
Modafinil—Chest pain—Methotrexate—lung cancer	8.02e-05	0.000335	CcSEcCtD
Modafinil—Myalgia—Methotrexate—lung cancer	8.02e-05	0.000335	CcSEcCtD
Modafinil—Tension—Doxorubicin—lung cancer	8.01e-05	0.000334	CcSEcCtD
Modafinil—Vomiting—Paclitaxel—lung cancer	8.01e-05	0.000334	CcSEcCtD
Modafinil—Dysgeusia—Doxorubicin—lung cancer	7.99e-05	0.000334	CcSEcCtD
Modafinil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	7.97e-05	0.000333	CcSEcCtD
Modafinil—Rash—Paclitaxel—lung cancer	7.94e-05	0.000331	CcSEcCtD
Modafinil—Dermatitis—Paclitaxel—lung cancer	7.93e-05	0.000331	CcSEcCtD
Modafinil—Discomfort—Methotrexate—lung cancer	7.93e-05	0.000331	CcSEcCtD
Modafinil—Nervousness—Doxorubicin—lung cancer	7.93e-05	0.000331	CcSEcCtD
Modafinil—Back pain—Doxorubicin—lung cancer	7.89e-05	0.000329	CcSEcCtD
Modafinil—Headache—Paclitaxel—lung cancer	7.89e-05	0.000329	CcSEcCtD
Modafinil—Hypersensitivity—Docetaxel—lung cancer	7.86e-05	0.000328	CcSEcCtD
Modafinil—Muscle spasms—Doxorubicin—lung cancer	7.85e-05	0.000327	CcSEcCtD
Modafinil—Confusional state—Methotrexate—lung cancer	7.76e-05	0.000324	CcSEcCtD
Modafinil—Anaphylactic shock—Methotrexate—lung cancer	7.69e-05	0.000321	CcSEcCtD
Modafinil—Asthenia—Docetaxel—lung cancer	7.66e-05	0.00032	CcSEcCtD
Modafinil—Infection—Methotrexate—lung cancer	7.64e-05	0.000319	CcSEcCtD
Modafinil—Nausea—Etoposide—lung cancer	7.63e-05	0.000318	CcSEcCtD
Modafinil—Ill-defined disorder—Doxorubicin—lung cancer	7.57e-05	0.000316	CcSEcCtD
Modafinil—Pruritus—Docetaxel—lung cancer	7.55e-05	0.000315	CcSEcCtD
Modafinil—Nervous system disorder—Methotrexate—lung cancer	7.54e-05	0.000315	CcSEcCtD
Modafinil—Anaemia—Doxorubicin—lung cancer	7.54e-05	0.000315	CcSEcCtD
Modafinil—Agitation—Doxorubicin—lung cancer	7.5e-05	0.000313	CcSEcCtD
Modafinil—Nausea—Paclitaxel—lung cancer	7.48e-05	0.000312	CcSEcCtD
Modafinil—Skin disorder—Methotrexate—lung cancer	7.47e-05	0.000312	CcSEcCtD
Modafinil—Hyperhidrosis—Methotrexate—lung cancer	7.44e-05	0.00031	CcSEcCtD
Modafinil—Malaise—Doxorubicin—lung cancer	7.36e-05	0.000307	CcSEcCtD
Modafinil—Vertigo—Doxorubicin—lung cancer	7.33e-05	0.000306	CcSEcCtD
Modafinil—Anorexia—Methotrexate—lung cancer	7.33e-05	0.000306	CcSEcCtD
Modafinil—Syncope—Doxorubicin—lung cancer	7.32e-05	0.000305	CcSEcCtD
Modafinil—Diarrhoea—Docetaxel—lung cancer	7.3e-05	0.000305	CcSEcCtD
Modafinil—Palpitations—Doxorubicin—lung cancer	7.21e-05	0.000301	CcSEcCtD
Modafinil—Hypotension—Methotrexate—lung cancer	7.19e-05	0.0003	CcSEcCtD
Modafinil—Loss of consciousness—Doxorubicin—lung cancer	7.17e-05	0.000299	CcSEcCtD
Modafinil—Cough—Doxorubicin—lung cancer	7.12e-05	0.000297	CcSEcCtD
Modafinil—Convulsion—Doxorubicin—lung cancer	7.07e-05	0.000295	CcSEcCtD
Modafinil—Dizziness—Docetaxel—lung cancer	7.06e-05	0.000295	CcSEcCtD
Modafinil—Hypertension—Doxorubicin—lung cancer	7.05e-05	0.000294	CcSEcCtD
Modafinil—Musculoskeletal discomfort—Methotrexate—lung cancer	7.01e-05	0.000292	CcSEcCtD
Modafinil—Insomnia—Methotrexate—lung cancer	6.96e-05	0.00029	CcSEcCtD
Modafinil—Arthralgia—Doxorubicin—lung cancer	6.95e-05	0.00029	CcSEcCtD
Modafinil—Chest pain—Doxorubicin—lung cancer	6.95e-05	0.00029	CcSEcCtD
Modafinil—Myalgia—Doxorubicin—lung cancer	6.95e-05	0.00029	CcSEcCtD
Modafinil—Anxiety—Doxorubicin—lung cancer	6.92e-05	0.000289	CcSEcCtD
Modafinil—Paraesthesia—Methotrexate—lung cancer	6.91e-05	0.000288	CcSEcCtD
Modafinil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	6.9e-05	0.000288	CcSEcCtD
Modafinil—Discomfort—Doxorubicin—lung cancer	6.87e-05	0.000286	CcSEcCtD
Modafinil—Dyspnoea—Methotrexate—lung cancer	6.86e-05	0.000286	CcSEcCtD
Modafinil—Somnolence—Methotrexate—lung cancer	6.84e-05	0.000285	CcSEcCtD
Modafinil—Dry mouth—Doxorubicin—lung cancer	6.8e-05	0.000284	CcSEcCtD
Modafinil—Vomiting—Docetaxel—lung cancer	6.79e-05	0.000283	CcSEcCtD
Modafinil—Dyspepsia—Methotrexate—lung cancer	6.77e-05	0.000283	CcSEcCtD
Modafinil—Rash—Docetaxel—lung cancer	6.73e-05	0.000281	CcSEcCtD
Modafinil—Dermatitis—Docetaxel—lung cancer	6.72e-05	0.000281	CcSEcCtD
Modafinil—Confusional state—Doxorubicin—lung cancer	6.72e-05	0.00028	CcSEcCtD
Modafinil—Decreased appetite—Methotrexate—lung cancer	6.69e-05	0.000279	CcSEcCtD
Modafinil—Headache—Docetaxel—lung cancer	6.69e-05	0.000279	CcSEcCtD
Modafinil—Anaphylactic shock—Doxorubicin—lung cancer	6.66e-05	0.000278	CcSEcCtD
Modafinil—Oedema—Doxorubicin—lung cancer	6.66e-05	0.000278	CcSEcCtD
Modafinil—Gastrointestinal disorder—Methotrexate—lung cancer	6.64e-05	0.000277	CcSEcCtD
Modafinil—Fatigue—Methotrexate—lung cancer	6.63e-05	0.000277	CcSEcCtD
Modafinil—Infection—Doxorubicin—lung cancer	6.62e-05	0.000276	CcSEcCtD
Modafinil—Pain—Methotrexate—lung cancer	6.58e-05	0.000275	CcSEcCtD
Modafinil—Shock—Doxorubicin—lung cancer	6.55e-05	0.000273	CcSEcCtD
Modafinil—Nervous system disorder—Doxorubicin—lung cancer	6.53e-05	0.000273	CcSEcCtD
Modafinil—Tachycardia—Doxorubicin—lung cancer	6.5e-05	0.000271	CcSEcCtD
Modafinil—Skin disorder—Doxorubicin—lung cancer	6.47e-05	0.00027	CcSEcCtD
Modafinil—Hyperhidrosis—Doxorubicin—lung cancer	6.44e-05	0.000269	CcSEcCtD
Modafinil—Anorexia—Doxorubicin—lung cancer	6.35e-05	0.000265	CcSEcCtD
Modafinil—Nausea—Docetaxel—lung cancer	6.34e-05	0.000265	CcSEcCtD
Modafinil—Feeling abnormal—Methotrexate—lung cancer	6.34e-05	0.000265	CcSEcCtD
Modafinil—Gastrointestinal pain—Methotrexate—lung cancer	6.29e-05	0.000262	CcSEcCtD
Modafinil—Methadone—ABCB1—lung cancer	6.28e-05	0.0121	CrCbGaD
Modafinil—Hypotension—Doxorubicin—lung cancer	6.22e-05	0.00026	CcSEcCtD
Modafinil—Urticaria—Methotrexate—lung cancer	6.11e-05	0.000255	CcSEcCtD
Modafinil—Abdominal pain—Methotrexate—lung cancer	6.08e-05	0.000254	CcSEcCtD
Modafinil—Body temperature increased—Methotrexate—lung cancer	6.08e-05	0.000254	CcSEcCtD
Modafinil—Musculoskeletal discomfort—Doxorubicin—lung cancer	6.07e-05	0.000253	CcSEcCtD
Modafinil—Insomnia—Doxorubicin—lung cancer	6.02e-05	0.000251	CcSEcCtD
Modafinil—Paraesthesia—Doxorubicin—lung cancer	5.98e-05	0.00025	CcSEcCtD
Modafinil—Dyspnoea—Doxorubicin—lung cancer	5.94e-05	0.000248	CcSEcCtD
Modafinil—Somnolence—Doxorubicin—lung cancer	5.92e-05	0.000247	CcSEcCtD
Modafinil—Dyspepsia—Doxorubicin—lung cancer	5.86e-05	0.000245	CcSEcCtD
Modafinil—Decreased appetite—Doxorubicin—lung cancer	5.79e-05	0.000242	CcSEcCtD
Modafinil—Gastrointestinal disorder—Doxorubicin—lung cancer	5.75e-05	0.00024	CcSEcCtD
Modafinil—Fatigue—Doxorubicin—lung cancer	5.74e-05	0.00024	CcSEcCtD
Modafinil—Pain—Doxorubicin—lung cancer	5.7e-05	0.000238	CcSEcCtD
Modafinil—Constipation—Doxorubicin—lung cancer	5.7e-05	0.000238	CcSEcCtD
Modafinil—Hypersensitivity—Methotrexate—lung cancer	5.67e-05	0.000237	CcSEcCtD
Modafinil—Asthenia—Methotrexate—lung cancer	5.52e-05	0.00023	CcSEcCtD
Modafinil—Feeling abnormal—Doxorubicin—lung cancer	5.49e-05	0.000229	CcSEcCtD
Modafinil—Gastrointestinal pain—Doxorubicin—lung cancer	5.45e-05	0.000227	CcSEcCtD
Modafinil—Pruritus—Methotrexate—lung cancer	5.44e-05	0.000227	CcSEcCtD
Modafinil—Urticaria—Doxorubicin—lung cancer	5.29e-05	0.000221	CcSEcCtD
Modafinil—Body temperature increased—Doxorubicin—lung cancer	5.27e-05	0.00022	CcSEcCtD
Modafinil—Abdominal pain—Doxorubicin—lung cancer	5.27e-05	0.00022	CcSEcCtD
Modafinil—Diarrhoea—Methotrexate—lung cancer	5.26e-05	0.00022	CcSEcCtD
Modafinil—Dizziness—Methotrexate—lung cancer	5.09e-05	0.000212	CcSEcCtD
Modafinil—Hypersensitivity—Doxorubicin—lung cancer	4.91e-05	0.000205	CcSEcCtD
Modafinil—Vomiting—Methotrexate—lung cancer	4.89e-05	0.000204	CcSEcCtD
Modafinil—Rash—Methotrexate—lung cancer	4.85e-05	0.000202	CcSEcCtD
Modafinil—Dermatitis—Methotrexate—lung cancer	4.85e-05	0.000202	CcSEcCtD
Modafinil—Headache—Methotrexate—lung cancer	4.82e-05	0.000201	CcSEcCtD
Modafinil—Asthenia—Doxorubicin—lung cancer	4.78e-05	0.000199	CcSEcCtD
Modafinil—Pruritus—Doxorubicin—lung cancer	4.71e-05	0.000197	CcSEcCtD
Modafinil—Nausea—Methotrexate—lung cancer	4.57e-05	0.000191	CcSEcCtD
Modafinil—Diarrhoea—Doxorubicin—lung cancer	4.56e-05	0.00019	CcSEcCtD
Modafinil—Dizziness—Doxorubicin—lung cancer	4.4e-05	0.000184	CcSEcCtD
Modafinil—Vomiting—Doxorubicin—lung cancer	4.24e-05	0.000177	CcSEcCtD
Modafinil—Rash—Doxorubicin—lung cancer	4.2e-05	0.000175	CcSEcCtD
Modafinil—Dermatitis—Doxorubicin—lung cancer	4.2e-05	0.000175	CcSEcCtD
Modafinil—Headache—Doxorubicin—lung cancer	4.17e-05	0.000174	CcSEcCtD
Modafinil—Nausea—Doxorubicin—lung cancer	3.96e-05	0.000165	CcSEcCtD
Modafinil—ADRA1B—Signaling Pathways—IGF1R—lung cancer	1.2e-05	0.000106	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—CXCL8—lung cancer	1.2e-05	0.000105	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—POMC—lung cancer	1.19e-05	0.000104	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—ALB—lung cancer	1.19e-05	0.000104	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—GSTP1—lung cancer	1.18e-05	0.000104	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—HES1—lung cancer	1.18e-05	0.000104	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—RRM1—lung cancer	1.18e-05	0.000103	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GSTA3—lung cancer	1.18e-05	0.000103	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—GSTT1—lung cancer	1.17e-05	0.000103	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—GNG11—lung cancer	1.17e-05	0.000103	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—lung cancer	1.17e-05	0.000103	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—GCLC—lung cancer	1.16e-05	0.000102	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CYP2A6—lung cancer	1.16e-05	0.000102	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—RAF1—lung cancer	1.16e-05	0.000102	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.16e-05	0.000102	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—GSTP1—lung cancer	1.16e-05	0.000101	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—CAT—lung cancer	1.15e-05	0.000101	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—IL2—lung cancer	1.14e-05	0.0001	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—PIK3CB—lung cancer	1.13e-05	9.93e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—CAT—lung cancer	1.12e-05	9.87e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—ABCB1—lung cancer	1.12e-05	9.83e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—ALDOA—lung cancer	1.12e-05	9.82e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—B4GALT5—lung cancer	1.1e-05	9.7e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—ENO1—lung cancer	1.1e-05	9.67e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—TYMS—lung cancer	1.1e-05	9.65e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.1e-05	9.63e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—ABCB1—lung cancer	1.09e-05	9.6e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—CXCL8—lung cancer	1.09e-05	9.54e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—GSTM1—lung cancer	1.09e-05	9.54e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—NCOA3—lung cancer	1.09e-05	9.53e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—CYP2E1—lung cancer	1.08e-05	9.51e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—ALB—lung cancer	1.08e-05	9.51e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—ERBB3—lung cancer	1.08e-05	9.48e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GSTA4—lung cancer	1.07e-05	9.44e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—TYMS—lung cancer	1.07e-05	9.43e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—NQO1—lung cancer	1.07e-05	9.4e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	1.07e-05	9.36e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—GSTM1—lung cancer	1.06e-05	9.32e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—ABCG2—lung cancer	1.06e-05	9.27e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—ADCY1—lung cancer	1.06e-05	9.27e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.05e-05	9.21e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GSTA2—lung cancer	1.05e-05	9.2e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1.04e-05	9.12e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—IL2—lung cancer	1.04e-05	9.12e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—HPGDS—lung cancer	1.04e-05	9.09e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—ENO2—lung cancer	1.04e-05	9.09e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—TERT—lung cancer	1.03e-05	9.09e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—CYP1A1—lung cancer	1.03e-05	9.04e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PPP2R1B—lung cancer	1.03e-05	9.03e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—ERCC2—lung cancer	1.02e-05	8.97e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—POMC—lung cancer	1.01e-05	8.91e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GSTA1—lung cancer	1.01e-05	8.88e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—CYP1A1—lung cancer	1.01e-05	8.84e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—FGFR1—lung cancer	1e-05	8.82e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—GSTT1—lung cancer	1e-05	8.82e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—ABCC3—lung cancer	9.99e-06	8.78e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—ERCC2—lung cancer	9.98e-06	8.77e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—GCLC—lung cancer	9.92e-06	8.72e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CYP2A6—lung cancer	9.92e-06	8.72e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—HIF1A—lung cancer	9.89e-06	8.69e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	9.89e-06	8.68e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CYP2E1—lung cancer	9.87e-06	8.67e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—NQO1—lung cancer	9.76e-06	8.58e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—AKR1C1—lung cancer	9.68e-06	8.5e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—STK11—lung cancer	9.65e-06	8.48e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	9.56e-06	8.4e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—APOA1—lung cancer	9.55e-06	8.38e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	9.47e-06	8.32e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—KDR—lung cancer	9.46e-06	8.31e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—ENO1—lung cancer	9.41e-06	8.26e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—UGT1A1—lung cancer	9.4e-06	8.25e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	9.37e-06	8.23e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—ALB—lung cancer	9.25e-06	8.13e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—lung cancer	9.06e-06	7.96e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GNG11—lung cancer	9.06e-06	7.96e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—GSTP1—lung cancer	8.93e-06	7.84e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—APOA1—lung cancer	8.83e-06	7.76e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—STK11—lung cancer	8.8e-06	7.73e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—KIT—lung cancer	8.72e-06	7.65e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—APC—lung cancer	8.72e-06	7.65e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PIK3CG—lung cancer	8.72e-06	7.65e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—NRAS—lung cancer	8.71e-06	7.65e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—CAT—lung cancer	8.69e-06	7.63e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—EP300—lung cancer	8.64e-06	7.59e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—APOA1—lung cancer	8.63e-06	7.58e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—ALDOA—lung cancer	8.63e-06	7.58e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—EGF—lung cancer	8.61e-06	7.57e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—ABCB1—lung cancer	8.45e-06	7.43e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CYP2E1—lung cancer	8.44e-06	7.41e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—NCOA3—lung cancer	8.37e-06	7.35e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—MAPK3—lung cancer	8.35e-06	7.33e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—NQO1—lung cancer	8.34e-06	7.33e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—TYMS—lung cancer	8.3e-06	7.29e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—POMC—lung cancer	8.3e-06	7.29e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	8.26e-06	7.26e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—GSTM1—lung cancer	8.21e-06	7.21e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—BRAF—lung cancer	8.19e-06	7.19e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	8.17e-06	7.18e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—ADCY1—lung cancer	8.15e-06	7.15e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—ABCG2—lung cancer	8.15e-06	7.15e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—GSTP1—lung cancer	8.14e-06	7.15e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	8.1e-06	7.11e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—IL6R—lung cancer	8.09e-06	7.11e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CREBBP—lung cancer	8.08e-06	7.1e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PIK3CG—lung cancer	8.06e-06	7.08e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—HPGDS—lung cancer	7.99e-06	7.02e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—ENO2—lung cancer	7.99e-06	7.02e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—EGFR—lung cancer	7.94e-06	6.97e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PPP2R1B—lung cancer	7.94e-06	6.97e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CAT—lung cancer	7.92e-06	6.96e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PIK3CG—lung cancer	7.88e-06	6.92e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	7.88e-06	6.92e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—CYP1A1—lung cancer	7.78e-06	6.83e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GSTT1—lung cancer	7.75e-06	6.81e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—ERCC2—lung cancer	7.72e-06	6.78e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—MAP2K1—lung cancer	7.71e-06	6.77e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—ABCB1—lung cancer	7.71e-06	6.77e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—POMC—lung cancer	7.68e-06	6.74e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PIK3CD—lung cancer	7.66e-06	6.73e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GCLC—lung cancer	7.66e-06	6.73e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CYP2A6—lung cancer	7.66e-06	6.73e-05	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—PIK3CA—lung cancer	7.59e-06	6.67e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—TYMS—lung cancer	7.57e-06	6.65e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—STK11—lung cancer	7.52e-06	6.61e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—POMC—lung cancer	7.5e-06	6.59e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—KRAS—lung cancer	7.5e-06	6.59e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—GSTM1—lung cancer	7.48e-06	6.57e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—CREBBP—lung cancer	7.48e-06	6.57e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—CREBBP—lung cancer	7.31e-06	6.42e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—ENO1—lung cancer	7.26e-06	6.38e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CYP1A1—lung cancer	7.09e-06	6.23e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PIK3CD—lung cancer	7.09e-06	6.23e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	7.06e-06	6.2e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—ERCC2—lung cancer	7.04e-06	6.18e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—ALB—lung cancer	7e-06	6.15e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—GSTP1—lung cancer	6.96e-06	6.11e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PIK3CD—lung cancer	6.93e-06	6.09e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—PIK3CA—lung cancer	6.89e-06	6.05e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—MDM2—lung cancer	6.86e-06	6.03e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—ALB—lung cancer	6.84e-06	6.01e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—RAF1—lung cancer	6.84e-06	6.01e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CAT—lung cancer	6.77e-06	5.95e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—ERBB2—lung cancer	6.77e-06	5.94e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—EP300—lung cancer	6.73e-06	5.91e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—MTOR—lung cancer	6.68e-06	5.87e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PIK3CB—lung cancer	6.68e-06	5.87e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—APOA1—lung cancer	6.68e-06	5.86e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—ABCB1—lung cancer	6.59e-06	5.79e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CYP2E1—lung cancer	6.51e-06	5.72e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—TYMS—lung cancer	6.47e-06	5.68e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—NQO1—lung cancer	6.44e-06	5.66e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CXCL8—lung cancer	6.42e-06	5.64e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—GSTM1—lung cancer	6.39e-06	5.62e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	6.39e-06	5.61e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—HRAS—lung cancer	6.38e-06	5.6e-05	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—AKT1—lung cancer	6.2e-06	5.44e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PIK3CB—lung cancer	6.18e-06	5.43e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CASP3—lung cancer	6.14e-06	5.39e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—IL2—lung cancer	6.13e-06	5.39e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PTGS2—lung cancer	6.12e-06	5.38e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—IL6—lung cancer	6.1e-06	5.36e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PIK3CG—lung cancer	6.09e-06	5.35e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—APOA1—lung cancer	6.09e-06	5.35e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CYP1A1—lung cancer	6.06e-06	5.32e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PIK3CB—lung cancer	6.04e-06	5.3e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—ERCC2—lung cancer	6.01e-06	5.28e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PTGS2—lung cancer	5.98e-06	5.26e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CCND1—lung cancer	5.98e-06	5.25e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—JUN—lung cancer	5.97e-06	5.24e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	5.83e-06	5.12e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—MMP9—lung cancer	5.8e-06	5.1e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—STK11—lung cancer	5.8e-06	5.1e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—POMC—lung cancer	5.8e-06	5.09e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CDKN1A—lung cancer	5.78e-06	5.08e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PTEN—lung cancer	5.77e-06	5.07e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—CREBBP—lung cancer	5.65e-06	4.96e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—AKT1—lung cancer	5.63e-06	4.94e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PIK3CG—lung cancer	5.56e-06	4.88e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—EP300—lung cancer	5.5e-06	4.83e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GSTP1—lung cancer	5.37e-06	4.72e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PIK3CD—lung cancer	5.36e-06	4.71e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—SRC—lung cancer	5.35e-06	4.7e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PTEN—lung cancer	5.34e-06	4.69e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—POMC—lung cancer	5.29e-06	4.65e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—ALB—lung cancer	5.29e-06	4.65e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CAT—lung cancer	5.23e-06	4.59e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PTEN—lung cancer	5.22e-06	4.58e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—VEGFA—lung cancer	5.21e-06	4.58e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—APOA1—lung cancer	5.2e-06	4.57e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—STAT3—lung cancer	5.16e-06	4.53e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CREBBP—lung cancer	5.15e-06	4.52e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—NRAS—lung cancer	5.15e-06	4.52e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—EP300—lung cancer	5.09e-06	4.47e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—ABCB1—lung cancer	5.08e-06	4.47e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—TYMS—lung cancer	4.99e-06	4.39e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	4.98e-06	4.37e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—EP300—lung cancer	4.98e-06	4.37e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GSTM1—lung cancer	4.94e-06	4.33e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—MAPK3—lung cancer	4.93e-06	4.33e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PIK3CD—lung cancer	4.88e-06	4.29e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—ALB—lung cancer	4.82e-06	4.24e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—MYC—lung cancer	4.8e-06	4.21e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PIK3CG—lung cancer	4.75e-06	4.17e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—EGFR—lung cancer	4.69e-06	4.12e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CYP1A1—lung cancer	4.68e-06	4.11e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PIK3CB—lung cancer	4.67e-06	4.1e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—ERCC2—lung cancer	4.64e-06	4.08e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PTGS2—lung cancer	4.63e-06	4.06e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—POMC—lung cancer	4.52e-06	3.97e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—KRAS—lung cancer	4.43e-06	3.89e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CREBBP—lung cancer	4.4e-06	3.87e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PIK3CB—lung cancer	4.26e-06	3.74e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PTGS2—lung cancer	4.22e-06	3.71e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PIK3CD—lung cancer	4.17e-06	3.67e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—ALB—lung cancer	4.12e-06	3.62e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PIK3CA—lung cancer	4.07e-06	3.58e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PTEN—lung cancer	4.04e-06	3.54e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—APOA1—lung cancer	4.01e-06	3.53e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—TP53—lung cancer	3.94e-06	3.46e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—EP300—lung cancer	3.85e-06	3.38e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PIK3CA—lung cancer	3.77e-06	3.31e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—HRAS—lung cancer	3.77e-06	3.31e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PIK3CA—lung cancer	3.68e-06	3.23e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PTEN—lung cancer	3.68e-06	3.23e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PIK3CG—lung cancer	3.66e-06	3.22e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PIK3CB—lung cancer	3.64e-06	3.2e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PTGS2—lung cancer	3.61e-06	3.17e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—IL6—lung cancer	3.6e-06	3.17e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—EP300—lung cancer	3.51e-06	3.08e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—POMC—lung cancer	3.49e-06	3.06e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CREBBP—lung cancer	3.4e-06	2.98e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—AKT1—lung cancer	3.33e-06	2.92e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PIK3CD—lung cancer	3.22e-06	2.83e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—ALB—lung cancer	3.18e-06	2.79e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PTEN—lung cancer	3.14e-06	2.76e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—AKT1—lung cancer	3.08e-06	2.7e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—AKT1—lung cancer	3.01e-06	2.64e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—EP300—lung cancer	3e-06	2.63e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PIK3CA—lung cancer	2.85e-06	2.5e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PIK3CB—lung cancer	2.81e-06	2.47e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PTGS2—lung cancer	2.78e-06	2.44e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PIK3CA—lung cancer	2.6e-06	2.28e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PTEN—lung cancer	2.43e-06	2.13e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—AKT1—lung cancer	2.33e-06	2.04e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—EP300—lung cancer	2.31e-06	2.03e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PIK3CA—lung cancer	2.22e-06	1.95e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—AKT1—lung cancer	2.12e-06	1.86e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—AKT1—lung cancer	1.81e-06	1.59e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PIK3CA—lung cancer	1.71e-06	1.5e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—AKT1—lung cancer	1.4e-06	1.23e-05	CbGpPWpGaD
